bioXcelerate AI

Our mission is to enable our clients to unlock research-driven insights into drug discovery and clinical development. This is made possible through our team of highly skilled data scientists, who leverage their academic knowledge to apply cutting-edge statistics, machine learning, and software engineering.  At our core is the ability to tailor solutions that meet our clients' unique needs and computational infrastructure, all in the pursuit of speeding up the journey to critical healthcare insights.  By skillfully orchestrating our toolkits and expertise, we construct fully bespoke, end-to-end solutions that align precisely with our clients' objectives and empower them to make data-driven decisions with confidence and efficiency.

Content by bioXcelerate AI

Illustration depicting the complex science, innovation and engineering needed to produce viable drugs.
| 3 min read
Page 1 of 1 - 1 Total Items
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
A group of blue capsules is scattered on a bright yellow surface, with one capsule opened to reveal white powder inside.

Understanding drug impurities: types, sources, and analytical strategies

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue